Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance
Clinicians have very limited options to treat triple-negative breast cancer (TNBC) due to the lack of effective targeted drugs. Recently, the findings of the mechanism underlying tumor-intrinsic immune escape have fueled a wave of studies into immunotherapy in breast cancer (BC). Compared with other...
Enregistré dans:
Auteurs principaux: | , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b70b5e3637074d7693e3d1e8c38ef8fc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|